Movement, function, pain, and postoperative edema in axillary web syndrome

Physical Therapy

Volumn 95, Issue 10, 2015, Pages 1345-1353

  Koehler, Linda A ^a   Blaes, Anne H ^a   Haddad, Tuffia C ^b   Hunter, David W ^c   Hirsch, Alan T ^c   Ludewig, Paula M ^c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVERSE EFFECTS; AGED; AXILLA; BODY MASS; BREAST NEOPLASMS; COHORT ANALYSIS; CONVALESCENCE; EDEMA; FEMALE; HUMAN; INCIDENCE; JOINT CHARACTERISTICS AND FUNCTIONS; LYMPH NODE DISSECTION; MASTECTOMY; MIDDLE AGED; PAIN, POSTOPERATIVE; PATHOPHYSIOLOGY; RISK FACTOR; SHOULDER; SYNDROME; TIME FACTOR;

ADULT; AGED; AXILLA; BODY MASS INDEX; BREAST NEOPLASMS; COHORT STUDIES; EDEMA; FEMALE; HUMANS; INCIDENCE; LYMPH NODE EXCISION; MASTECTOMY; MIDDLE AGED; PAIN, POSTOPERATIVE; RANGE OF MOTION, ARTICULAR; RECOVERY OF FUNCTION; RISK FACTORS; SHOULDER; SYNDROME; TIME FACTORS;

EID: 84943328583     PISSN: 00319023     EISSN: 15386724     Source Type: Journal    
DOI: 10.2522/ptj.20140377     Document Type: Article

References (38)

1. Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005;23: 7703-7720.
2. Aerts PD, De Vries J, Van der Steeg AF, Roukema JA. The relationship between morbidity after axillary surgery and long-term quality of life in breast cancer patients: the role of anxiety. Eur J Surg Oncol. 2011;37:344-349.
3. Akinci M, Cetin B, Aslan S, Kulacoglu H. Factors affecting seroma formation after mastectomy with full axillary dissection. Acta Chir Belg. 2009;109:481-483.
4. Hayes SC, Rye S, Battistutta D, et al. Upper-body morbidity following breast cancer treatment is common, may persist longer-term and adversely influences quality of life. Health Qual Life Outcomes. 2010;8: 92.
5. Nesvold IL, Dahl AA, Lokkevik E, et al. Arm and shoulder morbidity in breast cancer patients after breast-conserving therapy versus mastectomy. Acta Oncol. 2008; 47:835-842.
6. Unalp HR, Onal MA. Analysis of risk factors affecting the development of seromas following breast cancer surgeries: seromas following breast cancer surgeries. Breast J. 2007;13:588-592.
7. Vitug AF, Newman LA. Complications in breast surgery. Surg Clin North Am. 2007; 87:431-451.
8. Wilke LG, McCall LM, Posther KE, et al. Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol. 2006;13: 491-500.
9. Torres Lacomba M, Mayoral Del Moral O, Coperias Zazo JL, et al. Axillary web syndrome after axillary dissection in breast cancer: a prospective study. Breast Cancer Res Treat. 2009;117:625-630.
10. Leidenius M, Leppanen E, Krogerus L, von Smitten K. Motion restriction and axillary web syndrome after sentinel node biopsy and axillary clearance in breast cancer. Am J Surg. 2003;185:127-130.
11. Moskovitz AH, Anderson BO, Yeung RS, et al. Axillary web syndrome after axillary dissection. Am J Surg. 2001;181:434-439.
12. Josenhans E. Physiotherapeutic treatment for axillary cord formation following breast cancer surgery. Pt_Zeitschrift fur Physiotherapeuten. 2007;59:868-878.
13. Springer BA, Levy E, McGarvey C, et al. Pre-operative assessment enables early diagnosis and recovery of shoulder function in patients with breast cancer. Breast Cancer Res Treat. 2010;120:135-147.
14. Hayes S, Janda M, Cornish B, et al. Lymphedema secondary to breast cancer: how choice of measure influences diagnosis, prevalence, and identifiable risk factors. Lymphology. 2008;41:18-28.
15. Shamley DR, Srinanaganathan R, Weather-all R, et al. Changes in shoulder muscle size and activity following treatment for breast cancer. Breast Cancer Res Treat. 2007;106:19-27.
16. Borstad JD, Szucs KA. Three-dimensional scapula kinematics and shoulder function examined before and after surgical treatment for breast cancer. Hum Mov Sci. 2012;31:408-418.
17. O'Toole J, Miller CL, Specht MC, et al. Cording following treatment for breast cancer. Breast Cancer Res Treat. 2013; 140:105-111.
18. Norkin C, White J. Measurement of Joint Motion: A Guide to Goniometry. 4th ed. Philadelphia, PA: FA Davis Co; 2009.
19. Harrington S, Michener LA, Kendig T, et al. Patient-reported upper extremity outcome measures used in breast cancer survivors: a systematic review. Arch Phys Med Rehabil. 2014;95:153-162.
20. Hudak PL, Amadio PC, Bombardier C; the Upper Extremity Collaborative Group (UECG). Development of an upper extremity outcome measure: the DASH (Disabilities of the Arm, Shoulder and Hand) [corrected]. Am J Ind Med. 1996; 29:602-608.
21. Beaton DE, Katz JN, Fossel AH, et al. Measuring the whole or the parts? Validity, reliability, and responsiveness of the Disabilities of the Arm, Shoulder and Hand outcome measure in different regions of the upper extremity. J Hand Ther. 2001; 14:128-146.
22. Price DD, McGrath PA, Rafii A, Buckingham B. The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain. 1983;17:45-56.
23. Casley-Smith JR, Casley-Smith JR. Modern treatment of lymphoedema, I: complex physical therapy: the first 200 Australian limbs. Australas J Dermatol. 1992;33:61-68.
24. Ward LC, Czerniec S, Kilbreath SL. Quantitative bioimpedance spectroscopy for the assessment of lymphoedema. Breast Cancer Res Treat. 2009;117:541-547.
25. Cornish B. Bioimpedance analysis: scientific background. Lymphat Res Biol. 2006; 4:47-50.
26. Alanen E, Lahtinen T, Nuutinen J. Measurement of dielectric properties of subcutaneous fat with open-ended coaxial sensors. Phys Med Biol. 1998;43:475-485.
27. Mayrovitz HN. Assessing local tissue edema in postmastectomy lymphedema. Lymphology. 2007;40:87-94.
28. Aimoto A, Matsumoto T. Noninvasive method for measuring the electrical properties of deep tissues using an open-ended coaxial probe. Med Eng Phys. 1996;18: 641-646.
29. Mayrovitz HN, Weingrad DN, Davey S. Local tissue water in at-risk and contralat-eral forearms of women with and without breast cancer treatment-related lymph-edema. Lymphat Res Biol. 2009;7:153-158.
30. Armer JM, Stewart BR. A comparison of four diagnostic criteria for lymphedema in a post-breast cancer population. Lymphat Res Biol. 2005;3:208-217.
31. Mayrovitz HN. Assessing lymphedema by tissue indentation force and local tissue water. Lymphology. 2009;42:88-98.
32. Portney L, Watkins M. Foundations of Clinical Research: Applications to Practice. 3rd ed. Upper Saddle River, NJ: Prentice-Hall Inc; 2008.
33. Franchignoni F, Vercelli S, Giordano A, et al. Minimal clinically important difference of the Disabilities of the Arm, Shoulder and Hand outcome measure (DASH) and its shortened version (QuickDASH). J Orthop Sports Phys Ther. 2014;44:30-39.
34. Lee JS, Hobden E, Stiell IG, Wells GA. Clinically important change in the visual analog scale after adequate pain control. Acad Emerg Med. 2003;10:1128-1130.
35. Cheville AL, Tchou J. Barriers to rehabilitation following surgery for primary breast cancer. J Surg Oncol. 2007;95:409-418.
36. McNeely ML, Campbell K, Ospina M, et al. Exercise interventions for upper-limb dysfunction due to breast cancer treatment. Cochrane Database Syst Rev. 2010;6: CD005211.
37. Mahamaneerat W, Shyu C, Stewart BR, Armer JM. Breast cancer treatment, BMI, post-op swelling/lymphoedema. J Lym-phoedema. 2008;3:38-44.
38. Bergmann A, Mendes VV, de Almeida Dias R, et al. Incidence and risk factors for axillary web syndrome after breast cancer surgery. Breast Cancer Res Treat. 2012;131: 987-992.